Research use only. Nothing on this page is medical advice.
It depends on the peptide. Hormone peptides show up in your blood within days. Fat loss takes months. Healing and skin peptides have little or no human timeline.
- Days: after one CJC-1295 injection, growth hormone (GH) stayed up for 6 days or more and IGF-1, a growth signal made in response to GH, for 9 to 11 days (1).
- Weeks: in the one melanotan II pilot, 2 of 3 men had darker skin about 3 weeks after starting (2).
- Months: semaglutide and tirzepatide weight loss was measured at 68 and 72 weeks (3, 4).
- Unknown: BPC-157 and TB-500 have no validated human timeline (5).
Jump to the timeline table, why timelines differ, when to reassess or the FAQ.
How long does each peptide take?
How to read the table. Approved: FDA-approved drug. Trials: published human trials. Thin: one or two small human studies. Almost none: no validated human timeline.
| Peptide | Goal | Time in human data | Main limit |
|---|---|---|---|
| Semaglutide | Weight loss | ApprovedAverage loss was 14.9% at week 68, against 2.4% on placebo (3) | Measured with lifestyle support, over 68 weeks |
| Tirzepatide | Weight loss | Approved72-week trial with a 20-week dose ramp-up. Weight fell 15.0% to 20.9% by week 72, depending on dose group, against 3.1% on placebo (4) | The ramp-up is part of the timeline |
| Tesamorelin | Belly fat in HIV | TrialsVisceral (deep belly) fat fell in 26-week and 6-month trials. The drop held at about 18% over 52 weeks (6, 7) | The effect did not last after treatment stopped (6) |
| CJC-1295 | GH and IGF-1 levels | ThinAfter one injection, GH rose 2 to 10 fold for 6 days or more and IGF-1 rose 1.5 to 3 fold for 9 to 11 days (1) | Healthy adults, hormone levels only. Body changes were not measured |
| Melanotan II | Tanning | ThinIn the one pilot, 2 of 3 men had darker skin about 3 weeks after starting a 2-week course (2) | Not approved. The pilot also reported nausea, fatigue and spontaneous erections |
| BPC-157 and TB-500 | Injury repair | Almost noneNo validated human timeline. One retrospective series (a look back at past cases): 7 of 12 people with chronic knee pain reported relief lasting over 6 months (8) | No validated dosing regimen and no completed mid-stage (phase II) trial (5) |
| GHK-Cu | Skin | Almost noneNo clear human timeline. A 2025 review found very few clinical studies of GHK-Cu for wrinkles (9) | Lab results do not give you a timeline |
For one goal in depth, see the guides to healing peptides, weight loss peptides and the melanotan II tanning peptide.
Why do some peptides work in days and others in months?
Because they do different jobs.
- A hormone signal shows up in your blood first. That is the CJC-1295 row (1).
- Changing fat, skin or tendon means building or removing tissue. In the trials above, that took 26 to 72 weeks (3, 4, 6).
- Approved drugs ramp up slowly on purpose. The tirzepatide trial spent its first 20 weeks raising the dose (4).
- Hormone levels are not results. The CJC-1295 trial measured blood levels, not body changes (1).
What speeds up or slows down results?
- The goal. Blood markers move first. Body changes come last.
- Lifestyle. The semaglutide trial paired the drug with a lifestyle program (3).
- Product quality. If the vial is not what the label says, no timeline applies. Match the lot number to its lab report with our COA guide.
- Stopping. Tesamorelin’s effect on belly fat did not last after treatment ended (6).
When should you reassess?
Compare your time on a peptide with the trial length in the table. Judging a 26-week peptide at week 2 tells you nothing.
If a peptide has no human timeline, you have no benchmark. Talk to a doctor before you start and while you use it, and stop if something feels wrong.
For the safety side, read are peptides safe for long-term use and side effects of ipamorelin. For injuries, see peptides for injury recovery and peptides for tendon repair. To compare sellers by what their lab reports show, use best peptide vendors.
Peptide timeline FAQ
How long do peptides take to work?
It depends on the peptide. Hormone peptides like CJC-1295 raise growth hormone and IGF-1 within days. Weight loss peptides were measured at 68 to 72 weeks in trials. BPC-157 and TB-500 have no validated human timeline.
How long does BPC-157 take to work?
No validated human timeline exists. The only human data is a retrospective series in which 7 of 12 people with chronic knee pain reported relief lasting over 6 months. That is not a controlled trial.
How long do peptides take to work for weight loss?
In the semaglutide trial, average loss was 14.9% at week 68. In the tirzepatide trial, it was 15.0% to 20.9% at week 72, depending on dose group. Both trials raised the dose gradually.
How long do peptides take to work for skin?
GHK-Cu has no clear human timeline. A 2025 review found very few clinical studies of it for wrinkles, so a promised timeframe has no trial behind it.
How long do growth hormone peptides take to work?
Blood levels move first. After one CJC-1295 injection, growth hormone (GH) stayed up for 6 days or more and IGF-1, a growth signal made in response to GH, for 9 to 11 days. The trial measured hormone levels, not body composition or recovery.
How long do tanning peptides take to work?
In the one melanotan II pilot, 2 of 3 men had darker skin about 3 weeks after starting a 2-week course. Melanotan II is not approved, and the pilot also reported nausea, fatigue and spontaneous erections.
How long do KLOW or GLOW peptides take to work?
No human timeline exists. Their ingredients have none either, and no published human trial has tested the blends. See KLOW vs GLOW.
Why have my peptides not worked yet?
Check the trial length for your peptide first, because many ran 26 to 72 weeks. Then check the vial: match the lot number to its lab report. If your peptide has no human timeline, talk to a doctor.
Sources
Show references (9)Hide references
- Teichman SL, et al. Prolonged stimulation of growth hormone and IGF-I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults. J Clin Endocrinol Metab 2006. Source
- Dorr RT, et al. Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide, in a pilot phase-I clinical study. Life Sci 1996. Source
- Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021. Source
- Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med 2022. Source
- Mateescu DM, et al. BPC-157 as an investigational peptide therapeutic: biopharmaceutical challenges, formulation strategies, and translational development barriers. 2026. Source
- Falutz J, et al. Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation. AIDS 2008. Source
- Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial. JAMA 2014. Source
- Vasireddi N, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J 2025. Source
- Mortazavi SM, et al. Topically applied GHK as an anti-wrinkle peptide: advantages, problems and prospective. Bioimpacts 2025. Source